AstraZeneca

AstraZeneca Covid vaccine Associated with rare neurological Disease in India, UK

NEW DELHI: Eleven people who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians…

3 years ago

Vietnam to Get 1m Dosages of Oxford vaccine per Week from July

HANOI: 1 million dosages of AstraZeneca's Covid-19 vaccine is going to be moved to Vietnam per week beginning next month…

3 years ago

Vietnam to Get 1 million doses of AstraZeneca vaccine per Week in July

HANOI: 1 million dosages of AstraZeneca's Covid-19 vaccine is going to be moved to Vietnam per week beginning next month…

3 years ago

AstraZeneca vaccine’s Primary investigator backs India’s 12-16 week Covishield Dosage gap

NEW DELHI: Backing the 12-16 weeks difference between both doses of Covishield from the nation, the primary researcher of this…

3 years ago

AstraZeneca, EU both claim Success in tussle over deliveries

BRUSSELS: AstraZeneca and the European Union both promised victory Friday at a courtroom tussle over allegations the coronavirus vaccine-maker wasn't…

3 years ago

Pfizer, Moderna Favored 2nd dose Following AstraZeneca

OTTAWA: Canada's National Advisory Committee on Immunization stated Thursday individuals who obtained the AstraZeneca vaccine because their very first dose…

3 years ago

Australia Limits Oxford vaccine on clotting Issues

SYDNEY: Australia urged that AstraZeneca's Covid-19 jab shouldn't be awarded to individuals below 60 on Thursday, a new blow to…

3 years ago

AstraZeneca Strikes in Covid Medication Growth

LONDON: Covid vaccine-maker AstraZeneca on Tuesday showed it had struck a drawback in trials of a remedy to the coronavirus.…

3 years ago

Pfizer, AstraZeneca vaccines protect against Delta Version: Lancet Research

LONDON: The Delta version of coronavirus, initially found in India, doubles the risk of hospitalisation in comparison using the Alpha…

3 years ago

AstraZeneca States antibody treatment Unsuccessful in preventing Covid-19 in Vulnerable patients

LONDON: Anglo-Swedish drugmaker AstraZeneca said on Tuesday a report on its monoclonal antibody therapy, AZD7442, did not fulfill the primary…

3 years ago